Saudi Pharmaceutical Industries Medical Appliances Corp. (SPIMACO) reported a net profit of SAR 91.3 million for H1 2018, a fall of 40.5 percent year-on-year (YoY), on incurring zakat expenses at SAR 21 million, compared to zero charges in H1 2017.
The company had also recorded one-off gains of SAR 46 million from selling securities investments in the first half of 2017.
Item | 6m 2017 | 6m 2018 | Change |
---|---|---|---|
Revenues | 697.74 | 677.58 | (2.9 %) |
Gross Income | 368.71 | 342.84 | (7.0 %) |
Operating Income | 99.43 | 65.80 | (33.8 %) |
Net Income | 147.78 | 69.69 | (52.8 %) |
Average Shares | 120.00 | 120.00 | - |
EPS (Riyals) | 1.23 | 0.58 | (52.8 %) |
The Q2 net profit decreased by 33.6 percent YoY to SAR 35.5 million, hurt by an increase in operating, selling, general and administrative expenses, as well as doubtful loan provisions.
When compared to Q1 2018, the company’s net earnings also dropped 36.4 percent, due to a decline in revenue and seasonal factors.
Item | Q2 2017 | Q2 2018 | Change |
---|---|---|---|
Revenues | 304.63 | 295.62 | (3.0 %) |
Gross Income | 156.13 | 155.28 | (0.5 %) |
Operating Income | 49.40 | 10.00 | (79.8 %) |
Net Income | 46.56 | 22.67 | (51.3 %) |
Average Shares | 120.00 | 120.00 | - |
EPS (Riyals) | 0.39 | 0.19 | (51.3 %) |
Item | Q1 2018 | Q2 2018 | Change |
---|---|---|---|
Revenues | 390.79 | 295.62 | (24.4 %) |
Gross Income | 197.32 | 155.28 | (21.3 %) |
Operating Income | 67.66 | 10.00 | (85.2 %) |
Net Income | 55.23 | 22.67 | (59.0 %) |
Average Shares | 120.00 | 120.00 | - |
EPS (Riyals) | 0.46 | 0.19 | (59.0 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2009 | 257.88 | 16.9 % | 108.57 | 9.0 % | 46.06 | 10.7 % |
Q2 2009 | 229.00 | 8.2 % | 81.53 | 9.0 % | 16.76 | 51.6 % |
Q3 2009 | 171.15 | 17.7 % | 72.49 | (2.5 %) | 18.81 | (11.9 %) |
Q4 2009 | 292.71 | (0.5 %) | 157.00 | 37.4 % | 64.46 | 67.5 % |
2009 | 950.74 | 9.0 % | 419.59 | 15.6 % | 146.09 | 29.8 % |
Q1 2010 | 274.33 | 6.4 % | 118.90 | 9.5 % | 52.94 | 14.9 % |
Q2 2010 | 252.34 | 10.2 % | 100.50 | 23.3 % | 21.50 | 28.3 % |
Q3 2010 | 191.40 | 11.8 % | 85.88 | 18.5 % | 20.68 | 9.9 % |
Q4 2010 | 319.57 | 9.2 % | 181.12 | 15.4 % | 70.70 | 9.7 % |
2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 165.82 | 13.5 % |
Q1 2011 | 252.08 | (8.1 %) | 123.51 | 3.9 % | 49.79 | (6.0 %) |
Q2 2011 | 292.08 | 15.7 % | 123.61 | 23.0 % | 30.59 | 42.3 % |
Q3 2011 | 209.24 | 9.3 % | 106.76 | 24.3 % | 33.19 | 60.5 % |
Q4 2011 | 375.82 | 17.6 % | 206.69 | 14.1 % | 76.86 | 8.7 % |
2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 191.36 | 15.4 % |
Q1 2012 | 303.14 | 20.3 % | 153.21 | 24.0 % | 63.10 | 26.7 % |
Q2 2012 | 286.64 | (1.9 %) | 140.91 | 14.0 % | 34.78 | 13.7 % |
Q3 2012 | 227.40 | 8.7 % | 113.28 | 6.1 % | 39.61 | 19.3 % |
Q4 2012 | 365.97 | (2.6 %) | 211.16 | 2.2 % | 63.57 | (17.3 %) |
2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 201.06 | 5.1 % |
Q1 2013 | 361.37 | 19.2 % | 184.62 | 20.5 % | 70.64 | 11.9 % |
Q2 2013 | 344.22 | 20.1 % | 179.12 | 27.1 % | 40.64 | 16.8 % |
Q3 2013 | 222.91 | (2.0 %) | 118.64 | 4.7 % | 35.37 | (10.7 %) |
Q4 2013 | 382.01 | 4.4 % | 226.14 | 7.1 % | 60.19 | (5.3 %) |
2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 205.58 | 2.2 % |
Q1 2014 | 405.21 | 12.1 % | 206.72 | 12.0 % | 76.05 | 7.7 % |
Q2 2014 | 371.14 | 7.8 % | 193.14 | 7.8 % | 44.90 | 10.5 % |
Q3 2014 | 266.02 | 19.3 % | 134.45 | 13.3 % | 31.26 | (11.6 %) |
Q4 2014 | 431.06 | 12.8 % | 261.80 | 15.8 % | 90.22 | 49.9 % |
2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 241.94 | 17.7 % |
Q1 2015 | 432.20 | 6.7 % | 225.86 | 9.3 % | 91.35 | 20.1 % |
Q2 2015 | 435.80 | 17.4 % | 210.95 | 9.2 % | 48.02 | 6.9 % |
Q3 2015 | 308.27 | 15.9 % | 131.32 | (2.3 %) | 24.69 | (21.0 %) |
Q4 2015 | 520.38 | 20.7 % | 266.38 | 1.7 % | 101.91 | 13.0 % |
2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 262.04 | 8.3 % |
Q1 2016 | 322.20 | (25.4 %) | 194.26 | (14.0 %) | 53.22 | (41.7 %) |
Q2 2016 | 339.54 | (22.1 %) | 183.58 | (13.0 %) | 27.50 | (42.7 %) |
Q3 2016 | 257.21 | (16.6 %) | 140.54 | 7.0 % | 9.14 | (63.0 %) |
Q4 2016 | 339.59 | (34.7 %) | 194.16 | (27.1 %) | 13.46 | (86.8 %) |
2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 103.32 | (60.6 %) |
Q1 2017 | 393.10 | 22.0 % | 212.58 | 9.4 % | 50.03 | (6.0 %) |
Q2 2017 | 304.63 | (10.3 %) | 156.13 | (15.0 %) | 49.40 | 79.6 % |
Q3 2017 | 277.62 | 7.9 % | 128.68 | (8.4 %) | 8.30 | (9.2 %) |
Q4 2017 | 410.69 | 20.9 % | 207.07 | 6.7 % | 58.60 | 335.5 % |
2017 | 1,386.04 | 10.1 % | 704.46 | (1.1 %) | 166.33 | 61.0 % |
Q1 2018 | 390.79 | (0.6 %) | 197.32 | (7.2 %) | 67.66 | 35.2 % |
Q2 2018 | 295.62 | (3.0 %) | 155.28 | (0.5 %) | 10.00 | (79.8 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2008 | 871.94 | 9.3 % | 362.97 | 11.1 % | 112.51 | 15.1 % |
2009 | 950.74 | 9.0 % | 419.59 | 15.6 % | 146.09 | 29.8 % |
2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 165.82 | 13.5 % |
2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 191.36 | 15.4 % |
2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 201.06 | 5.1 % |
2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 205.58 | 2.2 % |
2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 241.94 | 17.7 % |
2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 262.04 | 8.3 % |
2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 103.32 | (60.6 %) |
2017 | 1,386.04 | 10.1 % | 704.46 | (1.1 %) | 166.33 | 61.0 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2009 | 42.69 | 4.3 % | 0.42 | (0.18) | 42.87 | 0.42 |
Q2 2009 | 37.81 | 10.4 % | 0.37 | 0.00 | 37.81 | 0.37 |
Q3 2009 | 15.84 | 1.4 % | 0.16 | 0.00 | 15.84 | 0.16 |
Q4 2009 | 58.48 | 56.0 % | 0.58 | (3.12) | 61.60 | 0.61 |
2009 | 154.81 | 20.7 % | 1.53 | (3.30) | 158.11 | 1.56 |
Q1 2010 | 45.32 | 6.2 % | 0.38 | (3.24) | 48.56 | 0.40 |
Q2 2010 | 43.09 | 14.0 % | 0.36 | - | 43.09 | 0.36 |
Q3 2010 | 18.07 | 14.1 % | 0.15 | - | 18.07 | 0.15 |
Q4 2010 | 70.04 | 19.8 % | 0.58 | - | 70.04 | 0.58 |
2010 | 176.52 | 14.0 % | 1.47 | (3.24) | 179.76 | 1.50 |
Q1 2011 | 45.71 | 0.9 % | 0.38 | - | 45.71 | 0.38 |
Q2 2011 | 60.75 | 41.0 % | 0.51 | - | 60.75 | 0.51 |
Q3 2011 | 29.75 | 64.6 % | 0.25 | - | 29.75 | 0.25 |
Q4 2011 | 74.06 | 5.7 % | 0.62 | - | 74.06 | 0.62 |
2011 | 211.44 | 19.8 % | 1.76 | - | 211.44 | 1.76 |
Q1 2012 | 56.45 | 23.5 % | 0.47 | - | 56.45 | 0.47 |
Q2 2012 | 90.14 | 48.4 % | 0.75 | - | 90.14 | 0.75 |
Q3 2012 | 32.33 | 8.7 % | 0.27 | - | 32.33 | 0.27 |
Q4 2012 | 53.73 | (27.5 %) | 0.45 | - | 53.73 | 0.45 |
2012 | 232.65 | 10.0 % | 1.94 | - | 232.65 | 1.94 |
Q1 2013 | 63.15 | 11.9 % | 0.53 | - | 63.15 | 0.53 |
Q2 2013 | 113.71 | 26.1 % | 0.95 | - | 113.71 | 0.95 |
Q3 2013 | 34.19 | 5.8 % | 0.28 | - | 34.19 | 0.28 |
Q4 2013 | 57.01 | 6.1 % | 0.48 | - | 57.01 | 0.48 |
2013 | 266.82 | 14.7 % | 2.22 | - | 266.82 | 2.22 |
Q1 2014 | 91.17 | 44.4 % | 0.76 | - | 91.17 | 0.76 |
Q2 2014 | 97.72 | (14.1 %) | 0.81 | - | 97.72 | 0.81 |
Q3 2014 | 36.69 | 7.3 % | 0.31 | - | 36.69 | 0.31 |
Q4 2014 | 91.29 | 60.1 % | 0.76 | - | 91.29 | 0.76 |
2014 | 316.85 | 18.8 % | 2.64 | - | 316.85 | 2.64 |
Q1 2015 | 99.39 | 9.0 % | 0.83 | - | 99.39 | 0.83 |
Q2 2015 | 237.63 | 143.2 % | 1.98 | 151.31 | 86.32 | 0.72 |
Q3 2015 | 29.16 | (20.5 %) | 0.24 | - | 29.16 | 0.24 |
Q4 2015 | (9.12) | (110.0 %) | (0.08) | (118.50) | 109.38 | 0.91 |
2015 | 357.05 | 12.7 % | 2.98 | 32.81 | 324.25 | 2.70 |
Q1 2016 | 88.91 | (10.5 %) | 0.74 | 15.46 | 73.45 | 0.61 |
Q2 2016 | 39.61 | (83.3 %) | 0.33 | - | 39.61 | 0.33 |
Q3 2016 | 4.76 | (83.7 %) | 0.04 | - | 4.76 | 0.04 |
Q4 2016 | 143.48 | 1673.8 % | 1.20 | 189.84 | (46.36) | (0.39) |
2016 | 276.76 | (22.5 %) | 2.31 | 205.30 | 71.46 | 0.60 |
Q1 2017 | 101.22 | 13.8 % | 0.84 | 46.14 | 55.08 | 0.46 |
Q2 2017 | 46.56 | 17.5 % | 0.39 | - | 46.56 | 0.39 |
Q3 2017 | (17.03) | (457.9 %) | (0.14) | - | (17.03) | (0.14) |
Q4 2017 | 66.61 | (53.6 %) | 0.56 | 13.40 | 53.21 | 0.44 |
2017 | 197.37 | (28.7 %) | 1.64 | 59.54 | 137.83 | 1.15 |
Q1 2018 | 55.23 | (45.4 %) | 0.46 | - | 55.23 | 0.46 |
Q2 2018 | 22.67 | (51.3 %) | 0.19 | - | 22.67 | 0.19 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2008 | 128.27 | 5.2 % | 1.26 | (3.89) | 132.16 | 1.30 |
2009 | 154.81 | 20.7 % | 1.53 | (3.30) | 158.11 | 1.56 |
2010 | 176.52 | 14.0 % | 1.47 | (3.24) | 179.76 | 1.50 |
2011 | 211.44 | 19.8 % | 1.76 | - | 211.44 | 1.76 |
2012 | 232.65 | 10.0 % | 1.94 | - | 232.65 | 1.94 |
2013 | 266.82 | 14.7 % | 2.22 | - | 266.82 | 2.22 |
2014 | 316.85 | 18.8 % | 2.64 | - | 316.85 | 2.64 |
2015 | 357.05 | 12.7 % | 2.98 | 32.81 | 324.25 | 2.70 |
2016 | 276.76 | (22.5 %) | 2.31 | 205.30 | 71.46 | 0.60 |
2017 | 197.37 | (28.7 %) | 1.64 | 59.54 | 137.83 | 1.15 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2009 | 40.91 % | 16.13 % | 14.83 % |
Q2 2009 | 40.87 % | 16.44 % | 14.89 % |
Q3 2009 | 39.57 % | 15.73 % | 14.07 % |
Q4 2009 | 44.13 % | 18.49 % | 16.63 % |
2009 | 44.13 % | 18.49 % | 16.63 % |
Q1 2010 | 44.45 % | 18.88 % | 16.94 % |
Q2 2010 | 45.32 % | 18.93 % | 17.07 % |
Q3 2010 | 45.73 % | 18.73 % | 16.95 % |
Q4 2010 | 46.88 % | 18.85 % | 17.32 % |
2010 | 46.88 % | 18.85 % | 17.32 % |
Q1 2011 | 48.36 % | 18.99 % | 17.42 % |
Q2 2011 | 48.73 % | 19.12 % | 18.44 % |
Q3 2011 | 49.86 % | 19.99 % | 19.22 % |
Q4 2011 | 49.64 % | 19.57 % | 18.62 % |
2011 | 49.64 % | 19.65 % | 18.72 % |
Q1 2012 | 50.01 % | 19.86 % | 18.73 % |
Q2 2012 | 51.72 % | 20.36 % | 21.31 % |
Q3 2012 | 51.47 % | 20.54 % | 21.21 % |
Q4 2012 | 52.28 % | 19.56 % | 19.66 % |
2012 | 52.28 % | 19.56 % | 19.66 % |
Q1 2013 | 52.36 % | 19.26 % | 19.28 % |
Q2 2013 | 52.98 % | 18.87 % | 20.24 % |
Q3 2013 | 53.58 % | 18.66 % | 20.45 % |
Q4 2013 | 54.06 % | 18.26 % | 20.45 % |
2013 | 54.06 % | 18.16 % | 20.36 % |
Q1 2014 | 53.95 % | 17.92 % | 21.86 % |
Q2 2014 | 53.91 % | 17.74 % | 20.28 % |
Q3 2014 | 53.39 % | 16.79 % | 19.84 % |
Q4 2014 | 54.03 % | 18.15 % | 21.50 % |
2014 | 54.04 % | 18.15 % | 21.55 % |
Q1 2015 | 54.34 % | 18.90 % | 21.67 % |
Q2 2015 | 53.23 % | 18.31 % | 20.04 % |
Q3 2015 | 51.63 % | 17.40 % | 19.05 % |
Q4 2015 | 49.19 % | 17.17 % | 19.11 % |
2015 | 49.77 % | 16.85 % | 19.02 % |
Q1 2016 | 50.60 % | 15.90 % | 18.80 % |
Q2 2016 | 52.04 % | 15.52 % | 16.88 % |
Q3 2016 | 54.52 % | 15.09 % | 15.79 % |
Q4 2016 | 56.62 % | 10.25 % | 5.68 % |
2016 | 56.62 % | 10.25 % | 5.68 % |
Q1 2017 | 54.97 % | 9.67 % | 3.99 % |
Q2 2017 | 54.34 % | 11.85 % | 4.64 % |
Q3 2017 | 52.59 % | 11.94 % | 2.91 % |
Q4 2017 | 50.83 % | 14.96 % | 9.94 % |
2017 | 50.83 % | 14.96 % | 9.94 % |
Q1 2018 | 49.81 % | 16.45 % | 9.97 % |
Q2 2018 | 50.07 % | 14.49 % | 8.30 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2008 | 41.63 % | 16.30 % | 15.16 % |
2009 | 44.13 % | 18.49 % | 16.63 % |
2010 | 46.88 % | 18.85 % | 17.32 % |
2011 | 49.64 % | 19.65 % | 18.72 % |
2012 | 52.28 % | 19.56 % | 19.66 % |
2013 | 54.06 % | 18.16 % | 20.36 % |
2014 | 54.04 % | 18.15 % | 21.55 % |
2015 | 49.77 % | 16.85 % | 19.02 % |
2016 | 56.62 % | 10.25 % | 5.68 % |
2017 | 50.83 % | 14.96 % | 9.94 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2009 | 42.10 % | 20.70 % | 16.62 % |
Q2 2009 | 35.60 % | 10.54 % | 16.51 % |
Q3 2009 | 42.35 % | 15.37 % | 9.25 % |
Q4 2009 | 53.64 % | 24.60 % | 21.04 % |
Q1 2010 | 43.34 % | 21.92 % | 17.70 % |
Q2 2010 | 39.83 % | 11.52 % | 17.08 % |
Q3 2010 | 44.87 % | 14.68 % | 9.44 % |
Q4 2010 | 56.68 % | 24.50 % | 21.92 % |
Q1 2011 | 49.00 % | 22.74 % | 18.13 % |
Q2 2011 | 42.32 % | 13.00 % | 20.80 % |
Q3 2011 | 51.02 % | 19.57 % | 14.22 % |
Q4 2011 | 55.00 % | 22.56 % | 19.71 % |
Q1 2012 | 50.54 % | 23.32 % | 18.62 % |
Q2 2012 | 49.16 % | 14.95 % | 31.45 % |
Q3 2012 | 49.82 % | 20.53 % | 14.22 % |
Q4 2012 | 57.70 % | 19.47 % | 14.68 % |
Q1 2013 | 51.09 % | 21.68 % | 17.48 % |
Q2 2013 | 52.04 % | 14.20 % | 33.03 % |
Q3 2013 | 53.22 % | 19.34 % | 15.34 % |
Q4 2013 | 59.20 % | 18.05 % | 14.92 % |
Q1 2014 | 51.02 % | 20.19 % | 22.50 % |
Q2 2014 | 52.04 % | 13.80 % | 26.33 % |
Q3 2014 | 50.54 % | 13.97 % | 13.79 % |
Q4 2014 | 60.73 % | 22.54 % | 21.18 % |
Q1 2015 | 52.26 % | 22.70 % | 23.00 % |
Q2 2015 | 48.40 % | 12.42 % | 19.81 % |
Q3 2015 | 42.60 % | 9.85 % | 9.46 % |
Q4 2015 | 51.19 % | 20.88 % | 21.02 % |
Q1 2016 | 60.29 % | 18.36 % | 22.80 % |
Q2 2016 | 54.07 % | 9.77 % | 11.67 % |
Q3 2016 | 54.64 % | 6.30 % | 1.85 % |
Q4 2016 | 57.18 % | 6.04 % | (13.65 %) |
Q1 2017 | 54.08 % | 14.94 % | 14.01 % |
Q2 2017 | 51.25 % | 19.02 % | 15.29 % |
Q3 2017 | 46.35 % | 7.17 % | (6.13 %) |
Q4 2017 | 50.42 % | 17.25 % | 12.96 % |
Q1 2018 | 50.49 % | 20.19 % | 14.13 % |
Q2 2018 | 52.53 % | 9.98 % | 7.67 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2009 | 101.51 | 1.28 | 1.33 | 14.17 |
Q2 2009 | 101.51 | 1.32 | 1.36 | 17.62 |
Q3 2009 | 101.51 | 1.32 | 1.32 | 19.72 |
Q4 2009 | 101.51 | 1.53 | 1.56 | 21.46 |
Q1 2010 | 120.00 | 1.31 | 1.36 | 22.04 |
Q2 2010 | 120.00 | 1.36 | 1.41 | 19.98 |
Q3 2010 | 120.00 | 1.37 | 1.43 | 21.69 |
Q4 2010 | 120.00 | 1.47 | 1.50 | 24.48 |
Q1 2011 | 120.00 | 1.47 | 1.47 | 25.41 |
Q2 2011 | 120.00 | 1.62 | 1.62 | 27.29 |
Q3 2011 | 120.00 | 1.72 | 1.72 | 25.92 |
Q4 2011 | 120.00 | 1.75 | 1.75 | 26.50 |
Q1 2012 | 120.00 | 1.84 | 1.84 | 30.26 |
Q2 2012 | 120.00 | 2.09 | 2.09 | 25.75 |
Q3 2012 | 120.00 | 2.11 | 2.11 | 26.24 |
Q4 2012 | 120.00 | 1.94 | 1.94 | 25.28 |
Q1 2013 | 120.00 | 1.99 | 1.99 | 27.18 |
Q2 2013 | 120.00 | 2.19 | 2.19 | 26.14 |
Q3 2013 | 120.00 | 2.21 | 2.21 | 27.35 |
Q4 2013 | 120.00 | 2.23 | 2.23 | 32.18 |
Q1 2014 | 120.00 | 2.47 | 2.47 | 32.96 |
Q2 2014 | 120.00 | 2.33 | 2.33 | 33.21 |
Q3 2014 | 120.00 | 2.35 | 2.35 | 35.74 |
Q4 2014 | 120.00 | 2.64 | 2.64 | 28.75 |
Q1 2015 | 120.00 | 2.71 | 2.71 | 27.84 |
Q2 2015 | 120.00 | 3.87 | 2.61 | 28.72 |
Q3 2015 | 120.00 | 3.81 | 2.55 | 24.87 |
Q4 2015 | 120.00 | 2.98 | 2.70 | 22.17 |
Q1 2016 | 120.00 | 2.89 | 2.49 | 20.84 |
Q2 2016 | 120.00 | 1.24 | 2.10 | 20.49 |
Q3 2016 | 120.00 | 1.03 | 1.89 | 20.40 |
Q4 2016 | 120.00 | 2.31 | 0.60 | 22.59 |
Q1 2017 | 120.00 | 2.41 | 0.44 | 23.27 |
Q2 2017 | 120.00 | 2.47 | 0.50 | 21.52 |
Q3 2017 | 120.00 | 2.29 | 0.32 | 22.01 |
Q4 2017 | 120.00 | 1.64 | 1.15 | 22.78 |
Q1 2018 | 120.00 | 1.26 | 1.15 | 25.04 |
Q2 2018 | 120.00 | 1.06 | 0.95 | 25.74 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2008 | 101.51 | 1.26 | 1.30 | 13.76 |
2009 | 101.51 | 1.53 | 1.56 | 21.46 |
2010 | 120.00 | 1.47 | 1.50 | 24.48 |
2011 | 120.00 | 1.76 | 1.76 | 26.50 |
2012 | 120.00 | 1.94 | 1.94 | 25.28 |
2013 | 120.00 | 2.22 | 2.22 | 32.18 |
2014 | 120.00 | 2.64 | 2.64 | 28.75 |
2015 | 120.00 | 2.98 | 2.70 | 22.17 |
2016 | 120.00 | 2.31 | 0.60 | 22.59 |
2017 | 120.00 | 1.64 | 1.15 | 22.78 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2009 | 14.92 | 14.39 | 1.35 |
Q2 2009 | 17.20 | 16.65 | 1.28 |
Q3 2009 | 18.29 | 18.26 | 1.22 |
Q4 2009 | 15.25 | 14.94 | 1.08 |
Q1 2010 | 16.69 | 16.04 | 0.99 |
Q2 2010 | 14.70 | 14.15 | 1.00 |
Q3 2010 | 14.64 | 14.10 | 0.93 |
Q4 2010 | 15.82 | 15.53 | 0.95 |
Q1 2011 | 17.65 | 17.65 | 1.02 |
Q2 2011 | 15.68 | 15.68 | 0.93 |
Q3 2011 | 14.41 | 14.41 | 0.96 |
Q4 2011 | 15.03 | 15.03 | 0.99 |
Q1 2012 | 17.92 | 17.92 | 1.09 |
Q2 2012 | 12.56 | 12.56 | 1.02 |
Q3 2012 | 13.70 | 13.70 | 1.10 |
Q4 2012 | 14.74 | 14.74 | 1.13 |
Q1 2013 | 13.60 | 13.60 | 1.00 |
Q2 2013 | 15.51 | 15.51 | 1.30 |
Q3 2013 | 15.70 | 15.70 | 1.27 |
Q4 2013 | 19.02 | 19.02 | 1.32 |
Q1 2014 | 19.07 | 19.07 | 1.43 |
Q2 2014 | 19.29 | 19.29 | 1.36 |
Q3 2014 | 21.41 | 21.41 | 1.41 |
Q4 2014 | 12.89 | 12.89 | 1.18 |
Q1 2015 | 14.78 | 14.78 | 1.44 |
Q2 2015 | 11.59 | 17.18 | 1.56 |
Q3 2015 | 9.46 | 14.14 | 1.45 |
Q4 2015 | 11.16 | 12.29 | 1.50 |
Q1 2016 | 11.15 | 12.96 | 1.55 |
Q2 2016 | 29.96 | 17.69 | 1.81 |
Q3 2016 | 30.18 | 16.49 | 1.53 |
Q4 2016 | 17.72 | 68.63 | 1.81 |
Q1 2017 | 15.03 | 81.82 | 1.56 |
Q2 2017 | 14.32 | 70.59 | 1.64 |
Q3 2017 | 14.43 | More than 100 | 1.50 |
Q4 2017 | 18.25 | 26.14 | 1.32 |
Q1 2018 | 24.34 | 26.70 | 1.23 |
Q2 2018 | 30.03 | 33.56 | 1.24 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2008 | 12.99 | 12.60 | 1.19 |
2009 | 15.25 | 14.94 | 1.08 |
2010 | 15.82 | 15.53 | 0.95 |
2011 | 14.95 | 14.95 | 0.99 |
2012 | 14.74 | 14.74 | 1.13 |
2013 | 19.11 | 19.11 | 1.32 |
2014 | 12.89 | 12.89 | 1.18 |
2015 | 11.16 | 12.29 | 1.50 |
2016 | 17.72 | 68.63 | 1.81 |
2017 | 18.25 | 26.14 | 1.32 |
Q1 2018
2018
Period | Pharmaceutical Manufacturing | healthy services and other | Trading & Distribution Services | Contract manufacturing arrangements | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
---|---|---|---|---|---|---|---|
Q1 2009 | - | - | - | - | 257.88 | - | - |
Q2 2009 | - | - | - | - | 229.00 | - | - |
Q3 2009 | - | - | - | - | 171.15 | - | - |
Q4 2009 | - | - | - | - | 292.71 | - | - |
Q1 2010 | - | - | - | - | 274.33 | - | - |
Q2 2010 | - | - | - | - | 252.34 | - | - |
Q3 2010 | - | - | - | - | 191.41 | - | - |
Q4 2010 | - | - | - | - | 319.57 | - | - |
Q1 2011 | - | - | - | - | 252.08 | - | - |
Q2 2011 | - | - | - | - | 292.08 | - | - |
Q3 2011 | - | - | - | - | 209.24 | - | - |
Q4 2011 | - | - | - | - | 375.82 | - | - |
Q1 2012 | - | - | - | - | 303.14 | - | - |
Q2 2012 | - | - | - | - | 286.65 | - | - |
Q3 2012 | - | - | - | - | 227.40 | - | - |
Q4 2012 | - | - | - | - | 365.97 | - | - |
Q1 2013 | - | - | - | - | 361.37 | - | - |
Q2 2013 | - | - | - | - | 344.22 | - | - |
Q3 2013 | - | - | - | - | 222.91 | - | - |
Q4 2013 | - | - | - | - | 382.01 | - | - |
Q1 2014 | - | - | - | - | 405.21 | - | - |
Q2 2014 | - | - | - | - | 374.14 | - | - |
Q3 2014 | - | - | - | - | 266.02 | - | - |
Q4 2014 | - | - | - | - | 427.82 | - | - |
Q1 2015 | - | - | - | - | 432.29 | 14.84 | - |
Q2 2015 | - | - | - | - | 436.99 | 195.93 | - |
Q3 2015 | - | - | - | - | 308.38 | 9.55 | - |
Q4 2015 | - | - | - | - | 529.24 | - | - |
Q1 2016 | - | - | - | - | 513.97 | 25.27 | - |
Q2 2016 | - | - | - | - | 494.92 | 9.41 | - |
Q3 2016 | - | - | - | - | 100.39 | 6.23 | - |
Q4 2016 | - | - | - | - | 401.35 | 247.84 | - |
Q1 2017 | - | - | - | - | 446.00 | 50.90 | (51.45) |
Q2 2017 | - | - | - | - | 350.01 | 1.39 | (43.30) |
Q3 2017 | - | - | - | - | 317.29 | 4.01 | (36.78) |
Q4 2017 | - | - | - | - | 486.15 | - | (54.74) |
Q1 2018 | - | - | - | - | 450.19 | 7.00 | (57.49) |
Period | Pharmaceutical Manufacturing | healthy services and other | Trading & Distribution Services | Contract manufacturing arrangements | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
---|---|---|---|---|---|---|---|
2008 | - | - | - | - | 871.94 | - | - |
2009 | - | - | - | - | 950.74 | - | - |
2010 | - | - | - | - | 1,037.64 | - | - |
2011 | - | - | - | - | 1,129.22 | - | - |
2012 | - | - | - | - | 1,183.15 | - | - |
2013 | - | - | - | - | 1,310.50 | - | - |
2014 | - | - | - | - | 1,470.19 | - | - |
2015 | - | - | - | - | 1,706.80 | 115.14 | - |
2016 | - | - | - | - | 1,510.63 | 288.74 | (244.41) |
2017 | - | - | - | - | 1,599.45 | 61.92 | (186.28) |
Item | Q2 2018 (e) | Q2 2018 (a) | Change |
---|---|---|---|
Average | 49.80 | 22.67 | (54.5 %) |
Item | Q2 2018 (e) | Q2 2018 (a) | Change |
---|---|---|---|
OSOOL AND BAKHEET | 49.80 | 22.67 | (54.5) % |
Current | |
Market Cap (M Riyal) | 3,804.00 |
Enterprise Value (EV) (M) | 5,073.60 |
Shares Outstanding ((M)) | 120.00 |
EPS ( Riyal) (TTM) | 0.10 |
Book Value (BV) ( Riyal) | 12.27 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | More than 100 |
P/E (TTM) | More than 100 |
Price/book | 2.58 |
Return on Average Assets (%) (TTM) | 0.3 |
Return on Average Equity (%) (TTM) | 0.8 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}